CClinicalTrials.gg
TerminatedNCT04966169Updated Aug 24, 2025

Effectiveness of GentleWave on the Healing of Apical Periodontitis: A Prospective Cohort Study

An interventional study of GentleWave System in Apical Periodontitis, sponsored by University of Iowa. Terminated at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2025-08-24.

Sponsored by University of Iowa · Not applicable, Interventional, and Treatment

Why this study was terminated
PI Departure from the University of Iowa
Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Not applicable
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The purpose of this 12-month prospective cohort study is to evaluate post-operatory pain, patient satisfaction, and treatment outcomes (i.e., healing) when the newly-developed, 510k FDA-approved multisonic energy GentleWAve System (Sonendo, Inc., Laguna Hills, CA) is used in complex root canal procedures.

Read the detailed description

Apical Periodontitis (AP) is a disease where multiple types of bacteria, including those that can live without oxygen, create a bacterial film on the tissues around teeth. These bacteria colonize the dying pulp tissue, invade channels within teeth and other openings, and create an inflammatory response of the tissues surrounding the teeth. Therefore, the primary goal of endodontic treatment is to reduce bacteria numbers by removing remaining tissues, bacterial films, and infected dentine (i.e., layer of tooth below the enamel). Healing of apical periodontitis (AP) is expected, in the majority of cases, if proper bacterial disinfection is accomplished.

Elimination of these bacteria can be achieved by a combined action of several treatments. Lately, irrigation and mechanical instrumentation techniques have been developed with this intention. Some new technologies are based on the concept of using minimally-invasive instruments with hydrodynamic cavitation generating a broad spectrum of sound waves within the degassed fluid inside of the tooth. However, there is not enough evidence in the literature to support its efficacy.

The hypothesis of this study is that the GentleWave (GW) hydrodynamic cavitation system (Sonendo, Inc., Laguna Hills, CA) will achieve a high success rate in treating and healing apical periodontitis (AP), a disease where a bacterial film is formed on the tissues around the teeth.

02

Conditions studied

  • Apical Periodontitis
03

In context

Periapical Periodontitis

246 studies on the registry are indexed under Periapical Periodontitis; 64 are open to participants now.

This study's enrollment of 23 is below the median of 60 across 211 interventional studies indexed under Periapical Periodontitis.

Browse Periapical Periodontitis studies →

Lead sponsor

University of Iowa is the lead sponsor of 276 studies on the registry; 35 are open to participants now.

Of its 44 completed or terminated interventional studies of FDA-regulated products, 39 (89%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18+ years
  • Speak and Read English
  • Able to attend follow-up visits at 6 months AND 1 year (post-baseline treatment)
  • A tooth with no response to cold and electric pulp testing.
  • Tooth is a 1st or 2nd mandibular molar
  • Tooth has no response to cold/electric pulp testing
  • Tooth has a diagnosis of pulp necrosis with asymptomatic apical periodontitis
  • 1st and 2nd mandibular molars.
  • Current (i.e., taken within the last week) radiograph available (or done at screening, as needed)
  • A limited-volume, cone-beam computed tomography (CBCT) taken at the first visit confirms apical periodontitis (radiolucency).

Exclusion criteria

Exclusion Criteria:

  • Patient has advanced untreated periodontal disease/recent periodontal surgery
  • Patient has non-odontogenic facial pan (e.g., face pain of unknown cause)
  • Patient has a history of poor attendance at dental visits
  • Patient is pregnant
  • Patient reports taking corticosteroids
  • Patient is supervised by the Principal Investigator or a member of the research team
  • Patient is subordinate to the Principal Investigator or a member of the research team
  • Patient is a student/trainee under the direction of the Principal Investigator or a member of the research team
  • Tooth had previous intervention (e.g., pulp debridement: removal of the pulp/nerve of the tooth)
  • Tooth has incomplete root formation (e.g., immature with apical periodontitis)
  • Tooth has defective restorations or carious lesions (i.e., cavities) that could lead to microleakage
  • Tooth has internal or external resorption
  • Tooth has a mobility score of 3
  • Tooth has a fracture/visibly cracked
  • Tooth has vital (i.e., functioning) pulp
  • Advanced untreated periodontal disease or recent periodontal surgery.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    Sonendo GentleWave

    Every participant will receive the same experimental treatment, which is root canal therapy using the Sonendo GentleWave System.

    Device: GentleWave System

Interventions

  • DeviceGentleWave System

    The GentleWave hydrodynamic cavitation system is a 510k FDA-approved multisonic energy system that is used in complex root canal procedures.

06

What researchers measure

Primary outcomes

  1. Change from baseline of Cone Beam Computed Tomography Periapical Index (CBCTPAI) across 1 year

    This will be assessed by the evaluator measuring the estimated tooth on the CBCT and assigning an index score on the CBCT. A score of 0 denotes an intact periapical bone structure. A score of 1 denotes a diameter of periapical radiolucency \>0.5-1mm. A score of 2 denotes a diameter of periapical radiolucency \>1-2mm. A score of 3 denotes a diameter of periapical radiolucency \>2-4mm. A score of 4 denotes a diameter of periapical radiolucency \>4-8mm. A score of 5 denotes a diameter of periapical radiolucency \>8mm. A score of 6 denotes (n) + E = expansion of periapical cortical bone. A score of 7 denotes (n) + D = destruction of periapical cortical bone.

    Time frame: Baseline; 6-months; 12 months

  2. Change from baseline of peripical index (PAI) across 1 year.

    This will be assessed by asking the evaluator to evaluate the PAI score at each X-ray. A value of 1 denotes normal periapical structures. A value of 2 denotes small changes in the bone structure. A value of 3 denotes changes in bone structure with some mineral loss. A value of 4 denotes apical periodontitis with well-defined radiolucent areas. A value of 5 denotes severe apical periodontitis with exacerbating features.

    Time frame: Baseline; 6-months post-baseline; 12 months post-baseline

  3. Change from baseline of modified wound healing scale (Mod-CWHS) across 1 year

    This will be assessed by the evaluator evaluating the research subject's healing status on a scale of 1-3. A value of 1 is "Uneventful wound healing with no gingival edema, erythema, suppuration, discomfort or barrier exposure. A value of 2 is "Uneventful wound healing with slight gingival edema, erythema, or discomfort but no suppuration. 3 is a value of poor wound healing with significant gingival edema, erythema, discomfort, loss of barrier or any suppuration.

    Time frame: 6 months post-baseline; 12 months post-baseline

  4. Change from baseline of pain severity in 0-10 pain severity scale across 1 year

    This will be assessed by asking the research subject their current level of pain on a 0-10 scale, and the patient will circle one line.

    Time frame: Baseline; 2 days post-baseline; 1 weeks post-baseline; 2 weeks post-baseline; 6 months post-baseline; 12-months post-baseline

  5. Change from Day 2 of research subject's thoughts on treatment result across 1 year.

    This will be assessed by asking the research subject to assess their own treatment result on a scale of 0 to 10 and circling one line.

    Time frame: 2 days post-baseline; 1-week post-baseline; 2-weeks post-baseline; 6-months post-baseline; 12 months post-baseline

07

Study locations

1 site
  • University of Iowa College of Dentistry and Dental Clinics
    Iowa City, Iowa 52242, United States
08

References and documents

Publications

  • Grigsby D Jr, Ordinola-Zapata R, McClanahan SB, Fok A. Postoperative Pain after Treatment Using the GentleWave System: A Randomized Controlled Trial. J Endod. 2020 Aug;46(8):1017-1022. doi: 10.1016/j.joen.2020.04.004. Epub 2020 Jun 14. PubMed 32553417 ↗
  • Sigurdsson A, Le KT, Woo SM, Rassoulian SA, McLachlan K, Abbassi F, Garland RW. Six-month healing success rates after endodontic treatment using the novel GentleWave System: The pure prospective multi-center clinical study. J Clin Exp Dent. 2016 Jul 1;8(3):e290-8. doi: 10.4317/jced.52779. eCollection 2016 Jul. PubMed 27398180 ↗
  • Sigurdsson A, Garland RW, Le KT, Woo SM. 12-month Healing Rates after Endodontic Therapy Using the Novel GentleWave System: A Prospective Multicenter Clinical Study. J Endod. 2016 Jul;42(7):1040-8. doi: 10.1016/j.joen.2016.04.017. PubMed 27325455 ↗
  • Wohlgemuth P, Cuocolo D, Vandrangi P, Sigurdsson A. Effectiveness of the GentleWave System in Removing Separated Instruments. J Endod. 2015 Nov;41(11):1895-8. doi: 10.1016/j.joen.2015.08.015. Epub 2015 Sep 26. PubMed 26409807 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04966169
Lead sponsor
University of Iowa
Responsible party
Sponsor
First posted
Jul 19, 2021
Start date
Aug 27, 2021
Primary completion
Jun 30, 2025
Completion
Jun 30, 2025
Last update
Aug 24, 2025

Study contacts

Fabricio Teixeira, DDS,MS,PhD
principal investigator · University of Iowa College of Dentistry

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion